Featured News Release

  • 4/27/17 4:30 pm EDT
    ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (NYSE: IVC) today reported it has completed the final two milestones required to initiate the United States Food and Drug Administration's (FDA) re-inspection of the company's Corporate and Taylor Street facilities, which have been impacted by a consent decree with FDA since December 2012. The re-inspection is an important step before the company may resume full operations at the impacted facilities. In order tomore...

Search Newsroom

Contact a member of the Invacare Public Relations Team >

Business Wire NewsHQ℠